Relief Therapeutics Announces Positive Final Results of RLF-TD011 Clinical Trial in Epidermolysis Bullosa
November 11, 2024
Host Chris Miglino interviews CFO Jim Heindlmeyer.
November 11, 2024
November 4, 2021
July 19, 2023
October 13, 2022
We use cookies to improve your experience on our site, to show you personalized advertising, and as otherwise described in our Cookie Policy . To find out more, read our Privacy Policy and our Cookie Policy.